2014 Hemostasis Gordon Research Conference and Gordon Research Seminar

2014止血戈登研究会议暨戈登研究研讨会

基本信息

  • 批准号:
    8784662
  • 负责人:
  • 金额:
    $ 1.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-07-15 至 2015-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): We request partial support for the Hemostasis Gordon Research Seminar (GRS) and Gordon Research Conference (GRC), which will be held at the GRC site in Waterville Valley, NH, July 26th through August 1st, 2014. The GRC meeting on hemostasis began in 1973 and has been held biennially since then. The 2014 conference represents the 32nd meeting in the series and is considered the premiere meeting for hemostasis-based research. The 2014 Hemostasis GRC meeting will be preceded by a GRS meeting dedicated to trainee development and exposure. The GRS meeting is organized and run by trainees, is highly successful, and enhances the profile of trainees at the GRC. The Hemostasis GRS/GRC brings together scientists interested in the biology, biochemistry and genetics of platelets and coagulation proteins, physicians involved in the treatment of bleeding and thrombotic diseases and investigators from small and large pharmaceutical companies developing new therapies for hemostatic disorders. The conference has legendary status establishing it as the forum at which cutting-edge research is presented and major advances in the field are unveiled. Indeed, some of the most spectacular recent achievements in hemostasis have been first unveiled at previous conferences in this series or have been driven by collaborative interactions fostered by this conference. The roster of invited speakers and discussion leaders who have agreed to participate in the GRS and GRC is impressive and represents top investigators in the field. These speakers and discussion leaders will enhance the stimulating nature of the environment for all attendees, especially junior investigators and trainees. The 2014 Hemostasis GRS and GRC programs include heightened participation from women, minorities, and young investigators compared to previous conferences. Moreover, the 2014 meeting will include a significant number of attendees who are junior faculty, students, postdoctoral fellows and individuals with physical disabilities. The 2014 Hemostasis GRS program includes a keynote presentation from Dr. Jane Freedman, a very successful female physician-scientist, 12 presentations from trainees, and 40 poster discussions. The 2014 Hemostasis GRC program will have 4 poster gatherings and 8 presentation sessions that include: 1. The Vessel Wall in Thrombosis and Coagulation; 2. Thrombosis and Coagulation During Infection; 3. Platelets and Coagulation Factors in Development and Disease; 4. Crosstalk in the Vascular Milieu; 5. Links Between Thrombosis, Coagulation, and Inflammation; 6. Coagulation and Platelets in Disease; 7. Hot Topic Abstract Talks where 8 trainees present their work; and, 8. Defective Hemostasis. The conference will end on the evening of August 1st with a keynote session entitled "The Impact of Mouse and Human Genetics on Thrombosis and Hemostasis".
描述(由申请人提供):

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Andrew S Weyrich其他文献

DECREASED TRANSENDOTHELIAL CELL MIGRATION IN NEONATES IS ASSOCIATED WITH DELAYED EXPRESSION OF P-SELECTION. ▴ 1754
  • DOI:
    10.1203/00006450-199604001-01778
  • 发表时间:
    1996-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Michael K Garyer;Andrew S Weyrich;Wenhua Li;Diane E Lorant
  • 通讯作者:
    Diane E Lorant

Andrew S Weyrich的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Andrew S Weyrich', 18)}}的其他基金

Translational Control of Megakaryocyte and Platelet Gene Expression in Disease
疾病中巨核细胞和血小板基因表达的转化控制
  • 批准号:
    10616557
  • 财政年份:
    2019
  • 资助金额:
    $ 1.25万
  • 项目类别:
Translational Control of Megakaryocyte and Platelet Gene Expression in Disease
疾病中巨核细胞和血小板基因表达的转化控制
  • 批准号:
    10569253
  • 财政年份:
    2019
  • 资助金额:
    $ 1.25万
  • 项目类别:
Patient Enrollment and Data Analysis
患者登记和数据分析
  • 批准号:
    8464249
  • 财政年份:
    2013
  • 资助金额:
    $ 1.25万
  • 项目类别:
Platelet Reprogramming in Human Obesity and Diabetes
人类肥胖和糖尿病中的血小板重编程
  • 批准号:
    8464247
  • 财政年份:
    2013
  • 资助金额:
    $ 1.25万
  • 项目类别:
Administrative
行政的
  • 批准号:
    8391960
  • 财政年份:
    2012
  • 资助金额:
    $ 1.25万
  • 项目类别:
Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes
重编程血小板:代谢综合征中血栓形成的效应器
  • 批准号:
    9068226
  • 财政年份:
    2012
  • 资助金额:
    $ 1.25万
  • 项目类别:
Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes
重编程血小板:代谢综合征中血栓形成的效应器
  • 批准号:
    8464229
  • 财政年份:
    2012
  • 资助金额:
    $ 1.25万
  • 项目类别:
Platelet Reprogramming in Human Obesity and Diabetes
人类肥胖和糖尿病中的血小板重编程
  • 批准号:
    8391959
  • 财政年份:
    2012
  • 资助金额:
    $ 1.25万
  • 项目类别:
Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes
重编程血小板:代谢综合征中血栓形成的效应器
  • 批准号:
    8656415
  • 财政年份:
    2012
  • 资助金额:
    $ 1.25万
  • 项目类别:
Human and Mouse Cell Isolation and Phenotyping
人类和小鼠细胞分离和表型分析
  • 批准号:
    8391963
  • 财政年份:
    2012
  • 资助金额:
    $ 1.25万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 1.25万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 1.25万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 1.25万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 1.25万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 1.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 1.25万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 1.25万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 1.25万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 1.25万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 1.25万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了